A Team Approach
Providing the best care for your child requires a large team of specialists. Our pediatric neurosurgeons, radiation oncologists, and neuro-oncologists (doctors who specialize in diagnosing and treating cancers that affect the brain and spine) work closely with you to create a personalized treatment plan. Your child’s care team also includes oncology nurses, nurse practitioners, physician assistants, social workers, cancer geneticists, nutritionists, physical therapists, occupational therapists, speech therapists, and others.
Prioritizing Comfort
We strive to make your child as comfortable as possible during treatment, and we work hard to minimize side effects and improve their overall quality of life. Our team includes experts in pain management, supportive nutrition, relaxation techniques, and therapies for coping with treatment and hospitalization. Our child life experts explain procedures in ways your child can understand, offer encouragement and emotional support, and use fun activities to take your child’s mind off treatment.
Care Continues After Treatment
Continuity of care after treatment is a critical component of excellent care, as children with brain and spinal tumors may face unique challenges after completing treatment.
- Your child’s follow-up care includes regular screenings, ongoing monitoring, and referrals to other specialists as needed.
- We help your child transition back to school.
- We help your child and family manage the immediate and long-term physical and emotional side effects of treatment.
Dedication to Research and Improved Outcomes
Duke has been at the forefront of important breakthroughs in treatments like immunotherapy and targeted therapies. Our pediatric program is part of the internationally recognized Preston Robert Tisch Brain Tumor Center, one of the earliest brain tumor research and clinical programs in the U.S. As members of the Pacific Pediatric Neuro-Oncology Consortium (PNOC) and Collaborative Network for Neuro-oncology Clinical Trials (CONNECT), we are dedicated to developing new and improved treatments for children with brain tumors.